about
Uric acid and dementia in community-dwelling older persons.Anabolic and catabolic biomarkers as predictors of muscle strength decline: the InCHIANTI studyObesity, poor muscle strength, and venous thromboembolism in older persons: the InCHIANTI studyCentral serous chorioretinopathy treated with navigated retinal laser photocoagulation: visual acuity and retinal sensitivity.Increased variance in germline allele-specific expression of APC associates with colorectal cancer.Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs.Frailty of older age: the role of the endocrine--immune interaction.From chronic low back pain to disability, a multifactorial mediated pathway: the InCHIANTI studyMarkers of inflammation, vitamin E and peripheral nervous system function: the InCHIANTI study.Correlates of bone quality in older persons.Erythropoietin and polyneuropathy in older personsMeasures of physical performance capture the excess disability associated with hip pain or knee pain in older persons.Potentially inappropriate medications and functional decline in elderly hospitalized patients.Viscosupplementation with intra-articular hyaluronic acid for treatment of osteoarthritis in the elderly.Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study.Walking training and cortisol to DHEA-S ratio in postmenopause: An intervention study.Cystatin C, adipokines and cardiovascular risk in HIV infected patients.Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up.The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia.Effects of hypertension on balance assessed by computerized posturography in the elderly.IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors.Blood pressure and intellectual function in elderly subjects.Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study.Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome.Effect of zinc ions on apoptosis in PBMCs from healthy aged subjects.Aging bone in men and women: beyond changes in bone mineral density.Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosisRANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1bPrednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathyPathological gambling in Parkinson disease is reduced by amantadineIncreased Production of Oncostatin-M by Lymphomononuclear Cells From HIV-1–Infected Patients With NeuroAIDSProinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients.A Xanalogical Collaborative Editing EnvironmentBlood pressure rhythm and prevalence of vascular events in hypertensive subjectsCardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertensionCorrelation between computed tomography findings of leukoaraiosis and 24-hour blood pressure variability in elderly subjectsAntihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients
P50
Q33646553-AFE89A23-44D7-4D75-9FCF-205BD85B5F43Q33905135-976C91C9-F281-4DB5-A344-1C4EA07AAD99Q34584612-7145E0A7-CF92-4AAE-8B3E-ADCADD33266DQ35598429-451D7130-6690-4A11-B7D5-BB0C1E234547Q35634864-9410834D-575D-4116-9ED2-E5E5193CF6DDQ35888602-4EC4E6DB-DF7B-4005-AB06-8FA2A4C3D836Q36570309-94DE5A95-65B1-41DD-8FEE-6148AEE8198AQ37104509-D3D49A84-8359-49D4-95AC-192825096214Q37105425-8A0C7E50-1FF3-4E0B-8F90-F8B646122497Q37105442-A68AD265-3E2A-4216-B18D-5F3C46234A70Q37174891-164E5E8A-5FF0-47D9-B383-24219EA6C473Q37413110-5967D3FE-157D-4737-84A8-2B23CFC1CD60Q37494742-349E63CF-BEC2-4F77-AE16-94159250ADD0Q37730128-B508C44F-7052-40BC-8D1F-84BD3BD6713CQ39555048-F853302E-9B7E-4F00-BED8-C311835FE39DQ40281026-B8BC7C12-58DB-4B0D-9BAB-8FA502ED5E81Q43082315-B28A393E-2475-4A79-9C97-726CF72BC879Q44085452-F398951D-E38A-403B-BC55-C112C2687B27Q44291664-EF40808C-1D66-451B-ACBD-D0FCCE886988Q44603358-06438A2B-B0A6-4916-A5D5-A308E087E621Q45225586-5C99756F-3084-421D-A5F1-551F504009C0Q47862694-A346F500-3748-469D-B776-6315220FEE81Q48771414-8288CB6F-DDE0-4B0B-BE17-D3B389121F85Q51932483-80E7B2EF-5746-4947-A048-0B33516DE274Q51965886-AD5E1947-771E-4A7D-9A21-88B87CAA64EDQ51978702-01A02AD2-9BA9-4B2C-8E66-5FEE6E9F7260Q52013556-D72CEB64-ED05-4DA5-8908-D1D500DE6D9EQ59389230-924D1D65-9E83-47F3-8B2C-B11167F4056CQ59389234-6427AAF0-BD7B-4140-BB48-1FC0618D0B0CQ59389244-5303FFEE-9143-49F2-BFA6-46ABF947C98FQ62078600-A705BF35-E5DF-4DFA-9ADC-110EC258A12BQ62660861-8254E557-77D0-417C-8488-FC7A458CAB82Q64936386-6C2C11AF-017A-4D6F-901E-32C3DDBE32E9Q67323859-6657c8e4-4573-afd4-ae53-0eb0bfb49006Q77324445-E0352840-5F2D-43B4-8CA7-1DCC1F50C810Q80865506-FA84ED8D-1F5C-4284-B37A-8020D7ED2F57Q81351725-162E18CD-4F7B-4984-BE5A-646EC2D0CD67Q84691807-BE870AC7-9C4C-4F28-A287-0C7453B08F05
P50
description
medical researcher
@en
wetenschapper
@nl
name
Angelo Di Iorio
@en
Angelo Di Iorio
@es
Angelo Di Iorio
@nl
type
label
Angelo Di Iorio
@en
Angelo Di Iorio
@es
Angelo Di Iorio
@nl
prefLabel
Angelo Di Iorio
@en
Angelo Di Iorio
@es
Angelo Di Iorio
@nl
P1053
Q-4458-2017
P1153
7003720178
P21
P31
P496
0000-0003-2899-146X